Table 3.
Complete and multiple imputation EQ-5D-5L results
| EQ-5D-5L data | Intervention | Unadjusted cost (£) (95% CI) |
Adjusted* incremental cost (£) (95% CI) |
Unadjusted† QALY (95% CI) |
Adjusted incremental QALY (95% CI) |
ICER (ΔCost/ ΔQALY) (£) | Probability of being cost-effective at different thresholds for a QALY | |||
| £0 | £20 000 | £30 000 | £50 000 | |||||||
| Complete case data (n=290) | Trabeculectomy (n=144) |
3686 (3435 to 3937) |
2089 (1762 to 2416) |
1.65 (1.61 to 1.69) |
0.03 (0.01 to 0.08) |
64 303 | 0 | 0% | 6% | 35% |
| Medical management (n=146) |
1605 (1390 to 1820) |
1.59 (1.55 to 1.64) |
100% | 100% | 94% | 65% | ||||
| Imputation data (n=403) | Trabeculectomy (n=199) |
3622 (3372 to 3872) |
2013 (1699 to 2327) |
1.61 (1.57 to 1.65) |
0.04 (−0.01 to 0.08) |
45 456 | 0 | 0% | 12% | 56% |
| Medical management (n=204) |
1605 (1409 to 1801) |
1.56 (1.52 to 1.60) |
100% | 100% | 88% | 44% | ||||
*Adjusted results are based on the results of the SUREG.
†Unadjusted results are based on the trial data.
ICER, Incremental Cost-Effectiveness Ratio; QALY, Quality-Adjusted Life-Year.